Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management
2d agoen
From the article
Conditions : Cancer Pain; Cancer Palliative Care Interventions : Drug: Metamizole; Drug: Ibuprofen; Other: Placebo Sponsors : University Hospital, Basel, Switzerland; Swiss GO Trial Group; Swiss National Science Foundation Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
FDA Approves First New Class of Non-Opioid Pain Drug, Offering Hope for Millions Suffering from Acute Pain
ltcnews.com·1y ago
https://www.cell.com/cell/fulltext/S0092-8674(26)00287-4
cell.com·1mo ago
FDA Approves First Non-Opioid Pain Reliever: Journavx by Vertex Pharmaceuticals
The FDA approved Vertex Pharmaceuticals's Journavx (suzetrigine) in January 2025, marking the first non-opioid pain reliever.
worksinprogress.news·1y ago
Prospective study of 197 cancer patients reports 84.4% clinical benefit rate with ivermectin and mebendazole combination
This prospective observational cohort study analyzed 197 cancer patients prescribed a combination of ivermectin and mebendazole off-label vi
ar.iiarjournals.org·15d agoChronic Pain in Older Adults: Strategies for Managing Discomfort
ltcnews.com·2y ago
Incomplete Article: Chronic Pain, Depression, and Brain Health References
This appears to be a truncated or incomplete article from Amen Clinics discussing the link between chronic pain, depression, and brain healt
amenclinics.com·8d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.